Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-000994
Filing Date
2024-06-20
Accepted
2024-06-20 16:15:03
Documents
107
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmmj_10q.htm   iXBRL 10-Q 1602844
2 CERTIFICATION bmmj_ex311.htm EX-31.1 12139
3 CERTIFICATION bmmj_ex312.htm EX-31.2 9757
4 CERTIFICATION bmmj_ex321.htm EX-32.1 3922
  Complete submission text file 0001640334-24-000994.txt   8694540

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bmmj-20240430.xsd EX-101.SCH 103230
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmmj-20240430_lab.xml EX-101.LAB 517375
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmmj-20240430_cal.xml EX-101.CAL 76770
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmmj-20240430_pre.xml EX-101.PRE 454464
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmmj-20240430_def.xml EX-101.DEF 284330
111 EXTRACTED XBRL INSTANCE DOCUMENT bmmj_10q_htm.xml XML 1525118
Mailing Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6
Business Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6 604-376-3567
BODY & MIND INC. (Filer) CIK: 0001715611 (see all company filings)

EIN.: 981319227 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55940 | Film No.: 241056381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)